These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

578 related articles for article (PubMed ID: 23174488)

  • 1. Plasma visfatin levels and gene expression in morbidly obese women with associated fatty liver disease.
    Auguet T; Terra X; Porras JA; Orellana-Gavaldà JM; Martinez S; Aguilar C; Lucas A; Pellitero S; Hernández M; Del Castillo D; Richart C
    Clin Biochem; 2013 Feb; 46(3):202-8. PubMed ID: 23174488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased levels and adipose tissue expression of visfatin in morbidly obese women: the relationship with pro-inflammatory cytokines.
    Terra X; Auguet T; Quesada I; Aguilar C; Luna AM; Hernández M; Sabench F; Porras JA; Martínez S; Lucas A; Pellitero S; Llutart J; del Castillo D; Richart C
    Clin Endocrinol (Oxf); 2012 Nov; 77(5):691-8. PubMed ID: 22182404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of weight loss induced by bariatric surgery on hepatic adipocytokine expression.
    Moschen AR; Molnar C; Wolf AM; Weiss H; Graziadei I; Kaser S; Ebenbichler CF; Stadlmann S; Moser PL; Tilg H
    J Hepatol; 2009 Oct; 51(4):765-77. PubMed ID: 19664840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinol binding protein-4 circulating levels were higher in nonalcoholic fatty liver disease vs. histologically normal liver from morbidly obese women.
    Terra X; Auguet T; Broch M; Sabench F; Hernández M; Pastor RM; Quesada IM; Luna A; Aguilar C; del Castillo D; Richart C
    Obesity (Silver Spring); 2013 Jan; 21(1):170-7. PubMed ID: 23505183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene expression of leptin, resistin, and adiponectin in the white adipose tissue of obese patients with non-alcoholic fatty liver disease and insulin resistance.
    Baranova A; Gowder SJ; Schlauch K; Elariny H; Collantes R; Afendy A; Ong JP; Goodman Z; Chandhoke V; Younossi ZM
    Obes Surg; 2006 Sep; 16(9):1118-25. PubMed ID: 16989692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adipose expression of adipocytokines in women with polycystic ovary syndrome.
    Svendsen PF; Christiansen M; Hedley PL; Nilas L; Pedersen SB; Madsbad S
    Fertil Steril; 2012 Jul; 98(1):235-41. PubMed ID: 22607892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retinol-binding protein 4 and nicotinamide phosphoribosyltransferase/visfatin in rat obesity models.
    Mercader J; Granados N; Caimari A; Oliver P; Bonet ML; Palou A
    Horm Metab Res; 2008 Jul; 40(7):467-72. PubMed ID: 18401839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver visfatin expression in morbidly obese patients with nonalcoholic fatty liver disease undergoing bariatric surgery.
    Kukla M; Ciupińska-Kajor M; Kajor M; Wyleżoł M; Żwirska-Korczala K; Hartleb M; Berdowska A; Mazur W
    Pol J Pathol; 2010; 61(3):147-53. PubMed ID: 21225497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fetuin-A mRNA expression is elevated in NASH compared with NAFL patients.
    Kahraman A; Sowa JP; Schlattjan M; Sydor S; Pronadl M; Wree A; Beilfuss A; Kilicarslan A; Altinbaş A; Bechmann LP; Syn WK; Gerken G; Canbay A
    Clin Sci (Lond); 2013 Oct; 125(8):391-400. PubMed ID: 23627434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma levels of PBEF/Nampt/visfatin are decreased in patients with liver cirrhosis.
    de Boer JF; Bahr MJ; Böker KH; Manns MP; Tietge UJ
    Am J Physiol Gastrointest Liver Physiol; 2009 Feb; 296(2):G196-201. PubMed ID: 19074645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulation of lipocalin 2 in adipose tissues of severely obese women: positive relationship with proinflammatory cytokines.
    Auguet T; Quintero Y; Terra X; Martínez S; Lucas A; Pellitero S; Aguilar C; Hernández M; del Castillo D; Richart C
    Obesity (Silver Spring); 2011 Dec; 19(12):2295-300. PubMed ID: 21455126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visfatin, TNF-alpha and IL-6 mRNA expression is increased in mononuclear cells from type 2 diabetic women.
    Tsiotra PC; Tsigos C; Yfanti E; Anastasiou E; Vikentiou M; Psarra K; Papasteriades C; Raptis SA
    Horm Metab Res; 2007 Oct; 39(10):758-63. PubMed ID: 17952840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of plasma visfatin with hepatic and systemic inflammation in nonalcoholic fatty liver disease.
    Genc H; Dogru T; Kara M; Tapan S; Ercin CN; Acikel C; Karslioglu Y; Bagci S
    Ann Hepatol; 2013; 12(4):548-55. PubMed ID: 23813132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adipokines and cytokines in non-alcoholic fatty liver disease.
    Jarrar MH; Baranova A; Collantes R; Ranard B; Stepanova M; Bennett C; Fang Y; Elariny H; Goodman Z; Chandhoke V; Younossi ZM
    Aliment Pharmacol Ther; 2008 Mar; 27(5):412-21. PubMed ID: 18081738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Visfatin/PBEF/Nampt and resistin expressions in circulating blood monocytes are differentially related to obesity and type 2 diabetes in humans.
    Laudes M; Oberhauser F; Schulte DM; Freude S; Bilkovski R; Mauer J; Rappl G; Abken H; Hahn M; Schulz O; Krone W
    Horm Metab Res; 2010 Apr; 42(4):268-73. PubMed ID: 20091460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver lipocalin 2 expression in severely obese women with non alcoholic fatty liver disease.
    Auguet T; Terra X; Quintero Y; Martínez S; Manresa N; Porras JA; Aguilar C; Orellana-Gavaldà JM; Hernández M; Sabench F; Lucas A; Pellitero S; Del Castillo D; Richart C
    Exp Clin Endocrinol Diabetes; 2013 Feb; 121(2):119-24. PubMed ID: 23426707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visfatin expression is elevated in normal human pregnancy.
    Morgan SA; Bringolf JB; Seidel ER
    Peptides; 2008 Aug; 29(8):1382-9. PubMed ID: 18524416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FABP 4 is associated with inflammatory markers and metabolic syndrome in morbidly obese women.
    Terra X; Quintero Y; Auguet T; Porras JA; Hernández M; Sabench F; Aguilar C; Luna AM; Del Castillo D; Richart C
    Eur J Endocrinol; 2011 Apr; 164(4):539-47. PubMed ID: 21257725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased serum resistin in nonalcoholic fatty liver disease is related to liver disease severity and not to insulin resistance.
    Pagano C; Soardo G; Pilon C; Milocco C; Basan L; Milan G; Donnini D; Faggian D; Mussap M; Plebani M; Avellini C; Federspil G; Sechi LA; Vettor R
    J Clin Endocrinol Metab; 2006 Mar; 91(3):1081-6. PubMed ID: 16394091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visfatin and its genetic variants are associated with obesity-related morbidities and cardiometabolic risk in severely obese children.
    Ooi SQ; Chan RM; Poh LK; Loke KY; Heng CK; Chan YH; Gan SU; Lee KO; Lee YS
    Pediatr Obes; 2014 Apr; 9(2):81-91. PubMed ID: 23447513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.